Can you fix healthcare and run a public company at the same time?
Join Accolade Chief Medical Officer, Dr. Shantanu Nundy, and SVP of Investor Relations, Todd Friedman, as they discuss how Accolade balances these two powerful, if at times conflicting, objectives.
This special event, hosted by Professor Les Funtleyder, will explore the current healthcare investing environment and discuss how Accolade approaches its obligations as a publicly-traded company while remaining focused on its core healthcare objectives. Topics will include a discussion of addressing health equity in a for-profit model, the impact of ESG investing on healthcare companies, the changing role of the Chief Medical Officer, the explosion of publicly traded HCIT companies during Covid, and an open Q&A time. The event will be followed by a reception with complimentary food and drinks.
722 w. 168th street, 4th floor, room 440
Email Becca Schoenfeld with any questions: [email protected]
Discussion
By posting you agree to the Terms and Privacy Policy.